Inappropriate Sexual Behaviour of Patients Towards French General Practitioners (#MedTooFr)

Inappropriate Sexual Behaviour (ISB) of Patients Towards French General Practitioners: Prevalence, Nature and Impact on Professional Practice

Occupational sexual harassment (HS) has come to the fore in recent years, particularly with the #MeToo social movement that has encouraged women victims of sexual violence to speak out around the world. The medical profession is not exempt from this phenomenon, whether during the training or professional life of practitioners. In France, very little data is available on this subject, particularly among general practitioners. However, the specific nature of the doctor-patient relationship in general practice makes it a potentially high-risk setting. Furthermore, practitioners' experiences of inappropriate sexual behaviour (ISB) can lead to changes in professional practice, and can thus directly influence the quality of care provided to patients. It is also described in the literature that sexual harassment in physicians is independently associated with a decrease in job satisfaction and sense of security at work, and may be associated with an altered mental health status. To date, the only French studies on ISB and HS in medicine have focused on the period of medical study, and none have looked at the particular problem of the patient as perpetrator of the violence. It is in this context that it has been decided to set up this cross-sectional study with the aim of evaluating the prevalence of ISB occurring during consultations with French general practitioners, to describe their characteristics and to evaluate the responses provided and the repercussions on professional practice.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

570

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Pierre, Réunion
        • CHU de la Réunion

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

General practitioners in private practice in France.

Description

Inclusion Criteria:

  • Any general practitioner
  • Male or female
  • Sole or mixed private practice
  • Installed or substitute
  • Having completed their internship in general medicine
  • With or without a thesis
  • Practising alone, in a group practice or in a health centre -

Exclusion Criteria:

  • Specialty other than general medicine
  • Exclusive hospital or salaried activity
  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence and nature of inappropriate sexual behaviour of patients towards general practitioners in private practice in France
Time Frame: Once at the inclusion visit
Determined by auto-administered questionnaire (sociodemographic data, personal experience, author's characteristics, reactions and answers provided by the practitioners)
Once at the inclusion visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence and nature of Inappropriate sexual behavior between men and women
Time Frame: Once at the inclusion visit
To compare the prevalence and nature of Inappropriate sexual behavior according to the gender of the responding physicians determined by auto-administered questionnaire
Once at the inclusion visit

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors associated with sexual inapropriate behavior
Time Frame: Once at the inclusion visit
Identify the risk factors associated determined by auto-administered questionnaire (author's characteristics provided by the practitioners)
Once at the inclusion visit
Responses of general practitioners to such a situation
Time Frame: Once at the inclusion visit
Types of responses provided by general practitioners to such a situation determined by auto-administered questionnaire (answers provided by the practitioners)
Once at the inclusion visit
Impact and changes on professional practice and personal life.
Time Frame: Once at the inclusion visit
Describe the impact and changes on professional practice and personal life determined by auto-administered questionnaire (reactions provided by the practitioners)
Once at the inclusion visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2022

Primary Completion (Actual)

January 15, 2022

Study Completion (Actual)

March 22, 2022

Study Registration Dates

First Submitted

November 4, 2021

First Submitted That Met QC Criteria

November 4, 2021

First Posted (Actual)

November 16, 2021

Study Record Updates

Last Update Posted (Actual)

April 1, 2022

Last Update Submitted That Met QC Criteria

March 31, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2021/CHU/18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sex Behavior

Clinical Trials on Questionnaire

3
Subscribe